Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis

• Published in: PLoS medicine 2020-10, Vol.17 (10), p.e1003361-e1003361
• Main Authors: Teramoto, Kanako, Santos, Mário, Claggett, Brian, John, Jenine E, Solomon, Scott D, Kitzman, Dalane, Folsom, Aaron R, Cushman, Mary, Matsushita, Kunihiro, Skali, Hicham, Shah, Amil M
• Format: Article
• Language: English
• Subjects: Age; Aged; Aged, 80 and over; Arteriosclerosis; Atherosclerosis; Biology and Life Sciences; Cardiac arrhythmia; Cardiovascular disease; Cardiovascular diseases; Chronic obstructive pulmonary disease; Cohort Studies; Coronary artery disease; Cross-Sectional Studies; Diabetes; Elderly; Female; Health aspects; Heart; Heart diseases; Heart failure; Heart Failure - epidemiology; Heart Failure - physiopathology; Heart Ventricles - physiopathology; Hemodynamics; Hospitalization; Humans; Hypertension; Laboratories; Lung diseases; Male; Medicine and Health Sciences; Prevalence; Prognosis; Prospective Studies; Pulmonary arteries; Pulmonary circulation; Risk factors; Stroke Volume; Surveillance; Thromboembolism; United States - epidemiology; Vascular resistance; Veins & arteries; Ventricle; Ventricular Function, Left - physiology
• ISSN: 1549-1676; 1549-1277; 1549-1676
• DOI: 10.1371/journal.pmed.1003361

Heart failure (HF) risk is highest in late life, and impaired pulmonary vascular function is a risk factor for HF development. However, data regarding the contributors to and prognostic importance of pulmonary vascular dysfunction among HF-free elders in the community are limited and largely restricted to pulmonary hypertension. Our objective was to define the prevalence and correlates of abnormal pulmonary pressure, resistance, and compliance and their association with incident HF and HF phenotype (left ventricular [LV] ejection fraction [LVEF] ≥ or < 50%) independent of LV structure and function. We performed cross-sectional and time-to-event analyses in a prospective epidemiologic cohort study, the Atherosclerosis Risk in Communities study. This is an ongoing, observational study that recruited 15,792 persons aged 45-64 years between 1987 and 1989 (visit 1) from four representative communities in the United States: Minneapolis, Minnesota; Jackson, Mississippi; Hagerstown, Maryland; and Forsyth County, North Carolina. The current analysis included 2,810 individuals aged 66-90 years, free of HF, who underwent echocardiography at the fifth study visit (June 8, 2011, to August 28, 2013) and had measurable tricuspid regurgitation by spectral Doppler. Echocardiography-derived pulmonary artery systolic pressure (PASP), pulmonary vascular resistance (PVR), and pulmonary arterial compliance (PAC) were measured. The main outcome was incident HF after visit 5, and key secondary end points were incident HF with preserved LVEF (HFpEF) and incident HF with reduced LVEF (HFrEF). The mean ± SD age was 76 ± 5 years, 66% were female, and 21% were black. Mean values of PASP, PVR, and PAC were 28 ± 5 mm Hg, 1.7 ± 0.4 Wood unit, and 3.4 ± 1.0 mL/mm Hg, respectively, and were abnormal in 18%, 12%, and 14%, respectively, using limits defined from the 10th and 90th percentile limits in 253 low-risk participants free of cardiovascular disease or risk factors. Left heart dysfunction was associated with abnormal PASP and PAC, whereas a restrictive ventilatory deficit was associated with abnormalities of PASP, PVR, and PAC. PASP, PVR, and PAC were each predictive of incident HF or death (hazard ratio per SD 1.3 [95% CI 1.1-1.4], p < 0.001; 1.1 [1.0-1.2], p = 0.04; 1.2 [1.1-1.4], p = 0.001, respectively) independent of LV measures. Elevated pulmonary pressure was predictive of incident HFpEF (HFpEF: 2.4 [1.4-4.0, p = 0.001]) but not HFrEF (1.4 [0.8-2.5, p = 0.31]). Abnormal PAC pre